Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 403-030-6 | CAS number: 137398-54-0 ROBAC AS/100
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Bacterial Reverse Gene Mutation Assay - The Ames Test
Introduction.
The object of the study was to assess the mutagenic potential of the test material in a bacterial system, following a test method based on OECD Guideline No. 471: Genetic Toxicology: Salmonella typhiumurium, Reverse Mutation Assay.
Methods.
Salmonella typhimurium strains TA 1535, TA 1537, TA 1538, TA 98 and TA 100 were used in the study.
The dose levels used were 5000, 500, 50 and 5 µg/plate in a dose range finding test, and 5000, 1500, 500, 150 and 50 µg/plate in the subsequent mutation tests.
Each dose level was tested in triplicate, both with and without metabolic activation (S9 mix).
Results.
In the dose range finding test, DIXT was not toxic towards the tester strains. Therefore 5000 µg/plate was chosen as the top dose level in the mutation tests.
No substantial increases in revertant colony numbers of any of the five tester strains were observed following treatment with DIXT at any dose level, either in the presence or absence of metabolic activation (S9 mix).
Conclusion.
It is concluded that no evidence of mutagenic potential of DIXT was obtained in this bacterial test system at the dose levels used.
Chromosome Aberration Test
DIXT was tested in vitro to determine whether it could cause chromosomal aberrations in a mammalian cell line derived from Chinese hamster ovary tissue. The cells were routinely grown and subcultured in tissue culture medium at 37°C in a humid atmosphere containing 5% carbon dioxide. They were incubated with the test compound both with and without supplementary metabolic activation (rat S9 mix).
A preliminary toxicity test was carried out to assess the effect of the compound on the mitotic index of cultured CHO cells. The results of this test indicated that a top dose level of 3 µg/ml should be used for the metaphase analysis in the absence of metabolic activation and 20 µg/ml in its presence.
In both the absence and presence of metabolic activation, DIXT caused no statistically significant increases in the level of chromosomal aberrations at any dose level, when compared with the solvent control.
Both positive control compounds showed statistically highly significant increases in the number of chromosomal aberrations when compared with solvent controls. This demonstrates the sensitivity of this test system and the efficacy of the S9 mix.
It is concluded that DIXT has shown no evidence of clastogenic activity in this in vitro cytogenetic test system.
Short description of key information:
In-vitro studies were conducted on the substance:
- Reverse mutation assay 'Ames Test' using S. typhimurium
- Chromosome aberration test in Chinese hamster ovary (CHO) cells
The studies gave negative results.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on negative results in the following in-vitro studies, the substance is not classified for mutagencity.
- Reverse mutation assay 'Ames Test' using S. typhimurium:
The test item was considered to be non-mutagenic under the conditions of this test.
- Chromosome aberration test in CHO cells:
The test item is considered to be non-clastogenic in this chromosome aberration test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.